About the Event

The impacts of the COVID-19 pandemic on the life science sector are being seen and felt worldwide, with various factors influencing key global markets. This BioForum will provide attendees with insight into the impact on the US healthtech market, with particular focus on factors that Australian businesses need to consider in relation to US market access.

US and Australian-based experts will provide an overview of the current landscape affecting medtech and biotech sectors in the US, delivering insights into the emerging risks to Australian businesses wanting to enter the US market, including how best to approach US business in the current climate. Impact to trade and global supply chains will also be considered, together with a review of current and emerging investment opportunities, and funding challenges that lie ahead.